Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87707227 | 8770722 | 7 | F | 20120828 | 20160906 | 20120907 | 20160912 | EXP | CA-ROCHE-GNE309708 | ROCHE | 63.18 | YR | F | Y | 94.00000 | KG | 20160912 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87707227 | 8770722 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E | 101612 | 300 | MG | SOLUTION FOR INJECTION | QOW | |||||
| 87707227 | 8770722 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E | 101612 | 300 | MG | SOLUTION FOR INJECTION | QOW | |||||
| 87707227 | 8770722 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E | 101612 | SOLUTION FOR INJECTION | ||||||||
| 87707227 | 8770722 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E | 101612 | SOLUTION FOR INJECTION | ||||||||
| 87707227 | 8770722 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0065E | 101612 | SOLUTION FOR INJECTION | ||||||||
| 87707227 | 8770722 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | U | 0 | 325 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 87707227 | 8770722 | 1 | Asthma |
| 87707227 | 8770722 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 87707227 | 8770722 | HO |
| 87707227 | 8770722 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 87707227 | 8770722 | Abdominal pain | |
| 87707227 | 8770722 | Blood pressure increased | |
| 87707227 | 8770722 | Body temperature decreased | |
| 87707227 | 8770722 | Diarrhoea | |
| 87707227 | 8770722 | Gastrointestinal disorder | |
| 87707227 | 8770722 | Haematochezia | |
| 87707227 | 8770722 | Heart rate increased | |
| 87707227 | 8770722 | Restlessness | |
| 87707227 | 8770722 | Urinary tract infection | |
| 87707227 | 8770722 | Weight decreased | |
| 87707227 | 8770722 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 87707227 | 8770722 | 1 | 20050809 | 0 | ||
| 87707227 | 8770722 | 2 | 20130211 | 0 | ||
| 87707227 | 8770722 | 3 | 20150310 | 0 | ||
| 87707227 | 8770722 | 4 | 20150323 | 0 | ||
| 87707227 | 8770722 | 5 | 20160419 | 0 |